Cataract surgery and nonsteroidal antiinflammatory drugs

The following summary from the ESCRS Publications Committee highlights why they consider this a 'Landmark' article.

Nice review of NSAIDs

A review of the use of nonsteroidal inflammatory drugs (NSAIDS) in cataract surgery highlights their potential, whether used alone, or synergistically with steroids, to the potential improve surgical outcomes. The authors not that In addition to their important ability to reduce the incidence of cystoid macular oedema (CME) for specific high-risk eyes prone to the development of the complication, the medications have been found to reduce pain, prevent intraoperative miosis, modulate postoperative inflammation. They add that a thorough understanding of preoperative, intraoperative, and postoperative uses of NSAIDs can help surgeons maximise the therapeutic benefits of the agents.

Author(s): Richard S. Hoffman, MD, Richard S. Hoffman, Rosa Braga-Mele, MD, Kendall Donaldson, MD, Geoffrey Emerick, MD, Bonnie Henderson, MD, Malik Kahook, MD, Nick Mamalis, MD, Kevin M. Miller, MD, Tony Realini, MD, MPH, Neal H. Shorstein, MD, Richard K. Stiverson, MD, Barbara Wirostko, MD

Source(s): JCRS

View Full Article

Other Landmark Article(s):

Back to previous


About the Portal

With our new range of online resources, you can continue your education year-round with ESCRS.

All of our resources together in one place:

  • iLearn (online CME accredited courses)
  • On Demand (A new updated layout for ease of use)
  • Player (videos from many different categories)
  • Landmark Journal Articles
  • Case Studies
  • Course Handouts and more…
Read more